Patent application number | Description | Published |
20090104142 | COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS - The present invention relates to compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis. | 04-23-2009 |
20100221219 | COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS - Compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis. | 09-02-2010 |
20100247577 | TR1 CELLS, MESENCHYMAL STEM CELLS AND USES THEREOF - The present invention relates to compositions comprising Tr1 cells and mesenchymal stem cells and methods for treating an autoimmune disease, an allergic disease or an inflammatory disease. | 09-30-2010 |
20100303780 | COMPOSITIONS FOR TREATING AN INTESTINAL INFLAMMATORY CONDITION - Compositions comprising human Tr1 cells directed to a food antigen from common human diet and methods for treating an intestinal inflammatory condition. | 12-02-2010 |
20110038844 | COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION - The present invention relates to compositions comprising human Tr1 cells directed to a joint-associated antigen and methods for treating an arthritic condition. | 02-17-2011 |
20110052535 | COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION - The present invention relates to a medicament comprising human Tr1 cells directed to a human HSP and methods for treating an inflammatory autoimmune condition. | 03-03-2011 |
20110311590 | COMPOSITIONS FOR TREATING AN ALLERGIC OR ASTHMATIC CONDITION - Compositions including human Tr1 cells directed to an allergen associated to an allergen or asthmatic provided the allergen is not a food allergen and use thereof for treating an allergic or asthmatic condition, excluding a food allergic condition. | 12-22-2011 |
20130034528 | NEW METHODS FOR ISOLATING TR1 CELLS - The present invention relates to methods for isolating Tr1 cells, resting Tr1 cells and/or activated Tr1 cells, to methods for enriching or depleting a cell population in Tr1 cells, resting Tr1 cells and/or activated Tr1 cells and to methods and kits for treating chronic inflammatory diseases, autoimmune diseases, allergic diseases, cancer and organ transplantation conditions. | 02-07-2013 |
20130101568 | IL-13 PRODUCING TR1-LIKE CELLS AND USE THEREOF - The present invention relates to an isolated Tr1-like cell population capable of producing IL-13, the population having immunosuppressive activities; methods for identifying/isolating/enriching the population and its uses thereof. | 04-25-2013 |
20130224784 | METHOD FOR ASSESSING THE EFFICACY OF A TR1 CELL THERAPY IN A SUBJECT - A method for assessing whether a patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, includes: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from the patient; and comparing the antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment. | 08-29-2013 |
20140044687 | METHOD FOR USING REGULATORY T CELLS IN THERAPY - A method of regulatory cell therapy for a treating a patient in need thereof, wherein 10 | 02-13-2014 |